BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calvo MB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010;2010. [PMID: 20706540 DOI: 10.1155/2010/205357] [Cited by in Crossref: 93] [Cited by in F6Publishing: 95] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Fu L, Wang Y, Tan J, Xu J, Gao Q, Chen Y, Fang J. Role of JMJD2B in colon cancer cell survival under glucose-deprived conditions and the underlying mechanisms. Oncogene 2018;37:389-402. [DOI: 10.1038/onc.2017.345] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
2 Jeong KY. Cancer-specific metabolism: Promising approaches for colorectal cancer treatment. World J Gastrointest Oncol 2019; 11(10): 768-772 [PMID: 31662818 DOI: 10.4251/wjgo.v11.i10.768] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Wang Y, Shu Y, Gu C, Fan Y. The novel sugar transporter SLC50A1 as a potential serum-based diagnostic and prognostic biomarker for breast cancer. Cancer Manag Res 2019;11:865-76. [PMID: 30697078 DOI: 10.2147/CMAR.S190591] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chen Y, Yang J, Fu S, Wu J. Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy. Int J Nanomedicine 2020;15:9407-30. [PMID: 33262595 DOI: 10.2147/IJN.S272902] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Barron CC, Bilan PJ, Tsakiridis T, Tsiani E. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Metabolism. 2016;65:124-139. [PMID: 26773935 DOI: 10.1016/j.metabol.2015.10.007] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 25.6] [Reference Citation Analysis]
6 Tang J, Ma D, Pecic S, Huang C, Zheng J, Li J, Yang R. Noninvasive and Highly Selective Monitoring of Intracellular Glucose via a Two-Step Recognition-Based Nanokit. Anal Chem 2017;89:8319-27. [PMID: 28707883 DOI: 10.1021/acs.analchem.7b01532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
7 Wang D, Chu PC, Yang CN, Yan R, Chuang YC, Kulp SK, Chen CS. Development of a novel class of glucose transporter inhibitors. J Med Chem 2012;55:3827-36. [PMID: 22468970 DOI: 10.1021/jm300015m] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
8 Aruleba RT, Adekiya TA, Oyinloye BE, Kappo AP. Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer. Int J Mol Sci 2018;19:E386. [PMID: 29382080 DOI: 10.3390/ijms19020386] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
9 Henriques AFA, Matos P, Carvalho AS, Azkargorta M, Elortza F, Matthiesen R, Jordan P. WNK1 phosphorylation sites in TBC1D1 and TBC1D4 modulate cell surface expression of GLUT1. Arch Biochem Biophys 2020;679:108223. [PMID: 31816312 DOI: 10.1016/j.abb.2019.108223] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
10 Guo T, Bai YH, Cheng XJ, Han HB, Du H, Hu Y, Jia SQ, Xing XF, Ji JF. Insulin gene enhancer protein 1 mediates glycolysis and tumorigenesis of gastric cancer through regulating glucose transporter 4. Cancer Commun (Lond) 2021;41:258-72. [PMID: 33570246 DOI: 10.1002/cac2.12141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Xintaropoulou C, Ward C, Wise A, Queckborner S, Turnbull A, Michie CO, Williams ARW, Rye T, Gourley C, Langdon SP. Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment. BMC Cancer 2018;18:636. [PMID: 29866066 DOI: 10.1186/s12885-018-4521-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
12 Raina K, Ravichandran K, Rajamanickam S, Huber KM, Serkova NJ, Agarwal R. Inositol hexaphosphate inhibits tumor growth, vascularity, and metabolism in TRAMP mice: a multiparametric magnetic resonance study. Cancer Prev Res (Phila) 2013;6:40-50. [PMID: 23213071 DOI: 10.1158/1940-6207.CAPR-12-0387] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
13 Itoh T, Tamura K, Ueda H, Tanaka T, Sato K, Kuroda R, Aoki S. Design and synthesis of boron containing monosaccharides by the hydroboration of d-glucal for use in boron neutron capture therapy (BNCT). Bioorg Med Chem 2018;26:5922-33. [PMID: 30420329 DOI: 10.1016/j.bmc.2018.10.041] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
14 Salker MS, Singh Y, Zeng N, Chen H, Zhang S, Umbach AT, Fakhri H, Kohlhofer U, Quintanilla-Martinez L, Durairaj RRP, Barros FSV, Vrljicak P, Ott S, Brucker SY, Wallwiener D, Vrhovac Madunić I, Breljak D, Sabolić I, Koepsell H, Brosens JJ, Lang F. Loss of Endometrial Sodium Glucose Cotransporter SGLT1 is Detrimental to Embryo Survival and Fetal Growth in Pregnancy. Sci Rep 2017;7:12612. [PMID: 28974690 DOI: 10.1038/s41598-017-11674-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
15 Fortunato S, Lenzi C, Granchi C, Citi V, Martelli A, Calderone V, Di Pietro S, Signore G, Di Bussolo V, Minutolo F. First Examples of H 2 S-Releasing Glycoconjugates: Stereoselective Synthesis and Anticancer Activities. Bioconjugate Chem 2019;30:614-20. [DOI: 10.1021/acs.bioconjchem.8b00808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
16 Holden L, Burke CS, Cullinane D, Keyes TE. Strategies to promote permeation and vectorization, and reduce cytotoxicity of metal complex luminophores for bioimaging and intracellular sensing. RSC Chem Biol 2021;2:1021-49. [PMID: 34458823 DOI: 10.1039/d1cb00049g] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Sędzikowska A, Szablewski L. Human Glucose Transporters in Renal Glucose Homeostasis. Int J Mol Sci 2021;22:13522. [PMID: 34948317 DOI: 10.3390/ijms222413522] [Reference Citation Analysis]
18 Korotcov AV, Ye Y, Chen Y, Zhang F, Huang S, Lin S, Sridhar R, Achilefu S, Wang PC. Glucosamine-linked near-infrared fluorescent probes for imaging of solid tumor xenografts. Mol Imaging Biol 2012;14:443-51. [PMID: 21971932 DOI: 10.1007/s11307-011-0520-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
19 Doshi M, Nierenberg DA, Flores-Fernandez O, Deme P, Becerra E, Khaled AR, Parthasarathy S. Cypate and Cypate-Glucosamine as Near-Infrared Fluorescent Probes for In Vivo Tumor Imaging. Mol Pharmacol 2019;95:475-89. [PMID: 30842252 DOI: 10.1124/mol.118.114199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
20 Allen-auerbach M, de Vos S, Czernin J. PET/Computed Tomography and Lymphoma. Radiologic Clinics of North America 2013;51:833-44. [DOI: 10.1016/j.rcl.2013.05.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Bruni L, Babarinde AA, Ortalli I, Croci S. K-D:rib dampens Hs 578T cancer cell chemoinvasion and proliferation. Cancer Cell Int 2014;14:77. [PMID: 25788860 DOI: 10.1186/s12935-014-0077-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Muñoz-Montesino C, Peña E, Roa FJ, Sotomayor K, Escobar E, Rivas CI. Transport of Vitamin C in Cancer. Antioxid Redox Signal 2021;35:61-74. [PMID: 33607936 DOI: 10.1089/ars.2020.8166] [Reference Citation Analysis]
23 Gerosa M, Grande MD, Busato A, Vurro F, Cisterna B, Forlin E, Gherlinzoni F, Morana G, Gottardi M, Matteazzi P, Speghini A, Marzola P. Nanoparticles exhibiting self-regulating temperature as innovative agents for Magnetic Fluid Hyperthermia. Nanotheranostics 2021;5:333-47. [PMID: 33732604 DOI: 10.7150/ntno.55695] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Piątkiewicz P, Bernat-Karpińska M, Miłek T, Rabijewski M, Rosiak E. NK cell count and glucotransporter 4 (GLUT4) expression in subjects with type 2 diabetes and colon cancer. Diabetol Metab Syndr 2016;8:38. [PMID: 27303448 DOI: 10.1186/s13098-016-0152-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
25 Hossain F, Andreana PR. Developments in Carbohydrate-Based Cancer Therapeutics. Pharmaceuticals (Basel) 2019;12:E84. [PMID: 31167407 DOI: 10.3390/ph12020084] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 9.3] [Reference Citation Analysis]
26 Hu C, Niestroj M, Yuan D, Chang S, Chen J. Treating cancer stem cells and cancer metastasis using glucose-coated gold nanoparticles. Int J Nanomedicine. 2015;10:2065-2077. [PMID: 25844037 DOI: 10.2147/ijn.s72144] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
27 Sharma B, Singh S, Kanwar SS. L-methionase: a therapeutic enzyme to treat malignancies. Biomed Res Int 2014;2014:506287. [PMID: 25250324 DOI: 10.1155/2014/506287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
28 Heydarzadeh S, Moshtaghie AA, Daneshpoor M, Hedayati M. Regulators of glucose uptake in thyroid cancer cell lines. Cell Commun Signal. 2020;18:83. [PMID: 32493394 DOI: 10.1186/s12964-020-00586-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhang R, Qin X, Kong F, Chen P, Pan G. Improving cellular uptake of therapeutic entities through interaction with components of cell membrane. Drug Deliv 2019;26:328-42. [PMID: 30905189 DOI: 10.1080/10717544.2019.1582730] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 21.3] [Reference Citation Analysis]
30 Pehlivanoglu S, Sahan OB, Pehlivanoglu S, Aktas Kont K. Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro. In Vitro Cell Dev Biol Anim 2021. [PMID: 34791627 DOI: 10.1007/s11626-021-00635-w] [Reference Citation Analysis]
31 Xiao L, Zou G, Cheng R, Wang P, Ma K, Cao H, Zhou W, Jin X, Xu Z, Huang Y, Lin X, Nie H, Jiang Q. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma. BMC Cancer 2021;21:703. [PMID: 34130646 DOI: 10.1186/s12885-021-08470-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
32 Khan H, Mirzaei HR, Amiri A, Kupeli Akkol E, Ashhad Halimi SM, Mirzaei H. Glyco-nanoparticles: New drug delivery systems in cancer therapy. Semin Cancer Biol 2021;69:24-42. [PMID: 31870939 DOI: 10.1016/j.semcancer.2019.12.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
33 Mikirova N, Casciari J, Riordan N, Hunninghake R. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients. J Transl Med 2013;11:191. [PMID: 23947403 DOI: 10.1186/1479-5876-11-191] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
34 Kubo T, Shimose S, Fujimori J, Furuta T, Arihiro K, Ochi M. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma? Clin Orthop Relat Res 2015;473:305-10. [PMID: 25193692 DOI: 10.1007/s11999-014-3910-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
35 GabAllah GMK, El-Din Habib MS, Soliman SE, Kasemy ZA, Gohar SF. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer. Saudi J Gastroenterol 2017;23:348-56. [PMID: 29205188 DOI: 10.4103/sjg.SJG_197_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Dapueto R, Castelli R, Fernández M, Chabalgoity JA, Moreno M, Gambini JP, Cabral P, Porcal W. Biological evaluation of glucose and deoxyglucose derivatives radiolabeled with [99mTc(CO)3(H2O)3]+ core as potential melanoma imaging agents. Bioorganic & Medicinal Chemistry Letters 2011;21:7102-6. [DOI: 10.1016/j.bmcl.2011.09.106] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
37 Talaia G, Gournas C, Saliba E, Barata-Antunes C, Casal M, André B, Diallinas G, Paiva S. The α-Arrestin Bul1p Mediates Lactate Transporter Endocytosis in Response to Alkalinization and Distinct Physiological Signals. J Mol Biol 2017;429:3678-95. [PMID: 28965784 DOI: 10.1016/j.jmb.2017.09.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
38 Fadlan A, Tanimoto H, Ito T, Aritomi Y, Ueno M, Tokuda M, Hirohara S, Obata M, Morimoto T, Kakiuchi K. Synthesis, photophysical properties, and photodynamic activity of positional isomers of TFPP-glucose conjugates. Bioorganic & Medicinal Chemistry 2018;26:1848-58. [DOI: 10.1016/j.bmc.2018.02.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Sodagar Taleghani A, Ebrahimnejad P, Heidarinasab A, Akbarzadeh A. Sugar-conjugated dendritic mesoporous silica nanoparticles as pH-responsive nanocarriers for tumor targeting and controlled release of deferasirox. Materials Science and Engineering: C 2019;98:358-68. [DOI: 10.1016/j.msec.2018.12.138] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
40 Lainé A, Passirani C. Novel metal-based anticancer drugs: a new challenge in drug delivery. Current Opinion in Pharmacology 2012;12:420-6. [DOI: 10.1016/j.coph.2012.04.006] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
41 Silvoniemi A, Din MU, Suilamo S, Shepherd T, Minn H. Radiotherapy volume delineation using dynamic [18F]-FDG PET/CT imaging in patients with oropharyngeal cancer: a pilot study. Int J Comput Assist Radiol Surg 2016;11:2059-69. [PMID: 26811083 DOI: 10.1007/s11548-016-1351-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
42 Glenister A, Chen CKJ, Paterson DJ, Renfrew AK, Simone MI, Hambley TW. Warburg Effect Targeting Co(III) Cytotoxin Chaperone Complexes. J Med Chem 2021;64:2678-90. [PMID: 33621096 DOI: 10.1021/acs.jmedchem.0c01875] [Reference Citation Analysis]
43 Singh S, Singh S, Sharma RK, Kaul A, Mathur R, Tomar S, Varshney R, Mishra AK. Synthesis and preliminary evaluation of a 99m Tc labelled deoxyglucose complex {[ 99m Tc]DTPA-bis(DG)} as a potential SPECT based probe for tumor imaging. New J Chem 2020;44:3062-71. [DOI: 10.1039/c9nj04705k] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
44 Hovsepian J, Defenouillère Q, Albanèse V, Váchová L, Garcia C, Palková Z, Léon S. Multilevel regulation of an α-arrestin by glucose depletion controls hexose transporter endocytosis. J Cell Biol 2017;216:1811-31. [PMID: 28468835 DOI: 10.1083/jcb.201610094] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
45 Reckzeh ES, Waldmann H. Small-Molecule Inhibition of Glucose Transporters GLUT-1-4. Chembiochem 2020;21:45-52. [PMID: 31553512 DOI: 10.1002/cbic.201900544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
46 Schindler E, Amantea MA, Karlsson MO, Friberg LE. PK-PD modeling of individual lesion FDG-PET response to predict overall survival in patients with sunitinib-treated gastrointestinal stromal tumor. CPT Pharmacometrics Syst Pharmacol 2016;5:173-81. [PMID: 27299707 DOI: 10.1002/psp4.12057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
47 Depeint F, Niamba C, Illner A, Buche-foissy C, Branchu J, Younes H, Loncke C, Pouillart PR. Investigating the Modifications of Sugar Perception and Consumption in Cancer Patients. Nutrition and Cancer 2018;70:1060-8. [DOI: 10.1080/01635581.2018.1494844] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Zi CT, Xu FQ, Li GT, Li Y, Ding ZT, Zhou J, Jiang ZH, Hu JM. Synthesis and anticancer activity of glucosylated podophyllotoxin derivatives linked via 4β-triazole rings. Molecules 2013;18:13992-4012. [PMID: 24232736 DOI: 10.3390/molecules181113992] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
49 Abolhasani A, Biria D, Abolhasani H, Zarrabi A, Komeili T. Investigation of the Role of Glucose Decorated Chitosan and PLGA Nanoparticles as Blocking Agents to Glucose Transporters of Tumor Cells. Int J Nanomedicine 2019;14:9535-46. [PMID: 31824149 DOI: 10.2147/IJN.S228652] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
50 Ung PM, Song W, Cheng L, Zhao X, Hu H, Chen L, Schlessinger A. Inhibitor Discovery for the Human GLUT1 from Homology Modeling and Virtual Screening. ACS Chem Biol 2016;11:1908-16. [PMID: 27128978 DOI: 10.1021/acschembio.6b00304] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
51 Libby CJ, Tran AN, Scott SE, Griguer C, Hjelmeland AB. The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells. Biochim Biophys Acta Rev Cancer 2018;1869:175-88. [PMID: 29378228 DOI: 10.1016/j.bbcan.2018.01.004] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 10.3] [Reference Citation Analysis]
52 Szablewski L. Expression of glucose transporters in cancers. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013;1835:164-9. [DOI: 10.1016/j.bbcan.2012.12.004] [Cited by in Crossref: 130] [Cited by in F6Publishing: 203] [Article Influence: 14.4] [Reference Citation Analysis]
53 Oyinloye BE, Adekiya TA, Aruleba RT, Ojo OA, Ajiboye BO. Structure-Based Docking Studies of GLUT4 Towards Exploring Selected Phytochemicals from Solanum xanthocarpum as a Therapeutic Target for the Treatment of Cancer. CDDT 2019;16:406-16. [DOI: 10.2174/1570163815666180801152110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
54 Suwabe Y, Nakano R, Namba S, Yachiku N, Kuji M, Sugimura M, Kitanaka N, Kitanaka T, Konno T, Sugiya H, Nakayama T. Involvement of GLUT1 and GLUT3 in the growth of canine melanoma cells. PLoS One 2021;16:e0243859. [PMID: 33539362 DOI: 10.1371/journal.pone.0243859] [Reference Citation Analysis]
55 Zunica ERM, Yang S, Coulter A, White C, Kirwan JP, Gilmore LA. Moringa Oleifera Seed Extract Concomitantly Supplemented with Chemotherapy Worsens Tumor Progression in Mice with Triple Negative Breast Cancer and Obesity. Nutrients 2021;13:2923. [PMID: 34578801 DOI: 10.3390/nu13092923] [Reference Citation Analysis]
56 Wu J, Pan D, Chung LW. Near-infrared fluorescence and nuclear imaging and targeting of prostate cancer. Transl Androl Urol 2013;2:254-64. [PMID: 25285271 DOI: 10.3978/j.issn.2223-4683.2013.09.05] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
57 Szablewski L. Distribution of glucose transporters in renal diseases. J Biomed Sci 2017;24:64. [PMID: 28854935 DOI: 10.1186/s12929-017-0371-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
58 Garcke H, Lam KF, Sitka E, Styles V. A Cahn–Hilliard–Darcy model for tumour growth with chemotaxis and active transport. Math Models Methods Appl Sci 2016;26:1095-148. [DOI: 10.1142/s0218202516500263] [Cited by in Crossref: 66] [Article Influence: 11.0] [Reference Citation Analysis]
59 Miyazawa T, Kamiyoshihara R, Shimizu N, Harigae T, Otoki Y, Ito J, Kato S, Miyazawa T, Nakagawa K. Amadori-glycated phosphatidylethanolamine enhances the physical stability and selective targeting ability of liposomes. R Soc Open Sci 2018;5:171249. [PMID: 29515844 DOI: 10.1098/rsos.171249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Krencz I, Sebestyen A, Papay J, Jeney A, Hujber Z, Burger CD, Keller CA, Khoor A. In situ analysis of mTORC1/2 and cellular metabolism-related proteins in human Lymphangioleiomyomatosis. Hum Pathol 2018;79:199-207. [PMID: 29885404 DOI: 10.1016/j.humpath.2018.05.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
61 Nguyen TT, Le NQ, Ho QT, Phan DV, Ou YY. Using word embedding technique to efficiently represent protein sequences for identifying substrate specificities of transporters. Anal Biochem 2019;577:73-81. [PMID: 31022378 DOI: 10.1016/j.ab.2019.04.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
62 Zha X, Hu Z, Ji S, Jin F, Jiang K, Li C, Zhao P, Tu Z, Chen X, Di L, Zhou H, Zhang H. NFκB up-regulation of glucose transporter 3 is essential for hyperactive mammalian target of rapamycin-induced aerobic glycolysis and tumor growth. Cancer Lett 2015;359:97-106. [PMID: 25578782 DOI: 10.1016/j.canlet.2015.01.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
63 Baudy AR, Dogan T, Flores-Mercado JE, Hoeflich KP, Su F, van Bruggen N, Williams SP. FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973. EJNMMI Res 2012;2:22. [PMID: 22651703 DOI: 10.1186/2191-219X-2-22] [Cited by in Crossref: 42] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
64 Do SK, Choi SH, Lee SY, Choi JE, Hong MJ, Kang H, Lee WK, Lee EB, Shin KM, Jeong JY, Lee YH, Seo H, Yoo SS, Lee J, Cha SI, Kim CH, Seok Y, Cho S, Jheon S, Park JY. Glucose transporter 3 gene variant is associated with survival outcome of patients with non-small cell lung cancer after surgical resection. Gene 2019;703:58-64. [DOI: 10.1016/j.gene.2019.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
65 Cucciolito ME, De Luca Bossa F, Esposito R, Ferraro G, Iadonisi A, Petruk G, D'elia L, Romanetti C, Traboni S, Tuzi A, Monti DM, Merlino A, Ruffo F. C -Glycosylation in platinum-based agents: a viable strategy to improve cytotoxicity and selectivity. Inorg Chem Front 2018;5:2921-33. [DOI: 10.1039/c8qi00664d] [Cited by in Crossref: 13] [Article Influence: 3.3] [Reference Citation Analysis]
66 Colas C, Ung PM, Schlessinger A. SLC Transporters: Structure, Function, and Drug Discovery. Medchemcomm 2016;7:1069-81. [PMID: 27672436 DOI: 10.1039/C6MD00005C] [Cited by in Crossref: 87] [Cited by in F6Publishing: 49] [Article Influence: 14.5] [Reference Citation Analysis]
67 Law WH, Lee LC, Louie M, Liu H, Ang TW, Lo KK. Phosphorescent Cellular Probes and Uptake Indicators Derived from Cyclometalated Iridium(III) Bipyridine Complexes Appended with a Glucose or Galactose Entity. Inorg Chem 2013;52:13029-41. [DOI: 10.1021/ic401714p] [Cited by in Crossref: 58] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
68 Tang Y, Zhang Z, Tang Y, Chen X, Zhou J. Identification of potential target genes in pancreatic ductal adenocarcinoma by bioinformatics analysis. Oncol Lett 2018;16:2453-61. [PMID: 30013637 DOI: 10.3892/ol.2018.8912] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
69 Liu R, Fu Z, Zhao M, Gao X, Li H, Mi Q, Liu P, Yang J, Yao Z, Gao Q. GLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugates. Oncotarget 2017;8:39476-96. [PMID: 28467806 DOI: 10.18632/oncotarget.17073] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
70 Dalby A, Bailey I. The Robustness of Pathway Analysis in Identifying Potential Drug Targets in Non-Small Cell Lung Carcinoma. Microarrays (Basel) 2014;3:212-25. [PMID: 27600345 DOI: 10.3390/microarrays3040212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
71 Zaritski A, Castillo-ecija H, Kumarasamy M, Peled E, Sverdlov Arzi R, Carcaboso ÁM, Sosnik A. Selective Accumulation of Galactomannan Amphiphilic Nanomaterials in Pediatric Solid Tumor Xenografts Correlates with GLUT1 Gene Expression. ACS Appl Mater Interfaces 2019;11:38483-96. [DOI: 10.1021/acsami.9b12682] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
72 Mushtaq M, Darekar S, Kashuba E. DNA Tumor Viruses and Cell Metabolism. Oxid Med Cell Longev 2016;2016:6468342. [PMID: 27034740 DOI: 10.1155/2016/6468342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
73 Kisková T, Kassayová M. Resveratrol Action on Lipid Metabolism in Cancer. Int J Mol Sci 2019;20:E2704. [PMID: 31159437 DOI: 10.3390/ijms20112704] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
74 Zhao Y, Wu Y, Xue B, Jin X, Zhu X. Novel target NIR-fluorescent polymer for living tumor cell imaging. Polym Chem 2019;10:77-85. [DOI: 10.1039/c8py01442f] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Andrejeva G, Rathmell JC. Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors. Cell Metab. 2017;26:49-70. [PMID: 28683294 DOI: 10.1016/j.cmet.2017.06.004] [Cited by in Crossref: 118] [Cited by in F6Publishing: 110] [Article Influence: 29.5] [Reference Citation Analysis]
76 Chouhan S, Singh S, Athavale D, Ramteke P, Vanuopadath M, Nair BG, Nair SS, Bhat MK. Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4. J Biosci 2020;45. [DOI: 10.1007/s12038-020-00065-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
77 Ramteke P, Deb A, Shepal V, Bhat MK. Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality. Cancers (Basel) 2019;11:E1402. [PMID: 31546918 DOI: 10.3390/cancers11091402] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
78 Stahl T, Hümmer S, Ehrenfeuchter N, Mittal N, Fucile G, Spang A. Asymmetric distribution of glucose transporter mRNA provides a growth advantage in yeast. EMBO J 2019;38:e100373. [PMID: 30910878 DOI: 10.15252/embj.2018100373] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N. The bio-energetic theory of carcinogenesis. Med Hypotheses 2012;79:433-9. [PMID: 22809841 DOI: 10.1016/j.mehy.2012.06.015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
80 Patra M, Awuah SG, Lippard SJ. Chemical Approach to Positional Isomers of Glucose-Platinum Conjugates Reveals Specific Cancer Targeting through Glucose-Transporter-Mediated Uptake in Vitro and in Vivo. J Am Chem Soc 2016;138:12541-51. [PMID: 27570149 DOI: 10.1021/jacs.6b06937] [Cited by in Crossref: 79] [Cited by in F6Publishing: 74] [Article Influence: 13.2] [Reference Citation Analysis]
81 Silsirivanit A. Glycosylation markers in cancer. Adv Clin Chem 2019;89:189-213. [PMID: 30797469 DOI: 10.1016/bs.acc.2018.12.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 9.3] [Reference Citation Analysis]
82 Tilekar K, Upadhyay N, Iancu CV, Pokrovsky V, Choe JY, Ramaa CS. Power of two: combination of therapeutic approaches involving glucose transporter (GLUT) inhibitors to combat cancer. Biochim Biophys Acta Rev Cancer. 2020;1874:188457. [PMID: 33096154 DOI: 10.1016/j.bbcan.2020.188457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
83 Lapa B, Gonçalves AC, Jorge J, Alves R, Pires AS, Abrantes AM, Coucelo M, Abrunhosa A, Botelho MF, Nascimento-Costa JM, Sarmento-Ribeiro AB. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target. Med Oncol 2020;37:72. [PMID: 32725458 DOI: 10.1007/s12032-020-01394-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
84 Li Y, Hong W, Zhang H, Zhang TT, Chen Z, Yuan S, Peng P, Xiao M, Xu L. Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy. Journal of Controlled Release 2020;317:232-45. [DOI: 10.1016/j.jconrel.2019.11.031] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
85 Hexige S, Ardito-Abraham CM, Wu Y, Wei Y, Fang Y, Han X, Li J, Zhou P, Yi Q, Maitra A, Liu JO, Tuveson DA, Lou W, Yu L. Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma. J Pathol 2015;236:142-54. [PMID: 25561062 DOI: 10.1002/path.4506] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
86 Wen L, Huang K, Zheng Y, Fang J, Kondengaden SM, Wang PG. Two-step enzymatic synthesis of 6-deoxy-L-psicose. Tetrahedron Lett 2016;57:3819-22. [PMID: 27546917 DOI: 10.1016/j.tetlet.2016.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
87 Gnana-Prakasam JP, Veeranan-Karmegam R, Coothankandaswamy V, Reddy SK, Martin PM, Thangaraju M, Smith SB, Ganapathy V. Loss of Hfe leads to progression of tumor phenotype in primary retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2013;54:63-71. [PMID: 23169885 DOI: 10.1167/iovs.12-10312] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
88 Song KH, Kang JH, Woo JK, Nam JS, Min HY, Lee HY, Kim SY, Oh SH. The novel IGF-IR/Akt-dependent anticancer activities of glucosamine. BMC Cancer 2014;14:31. [PMID: 24438088 DOI: 10.1186/1471-2407-14-31] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
89 McCracken AN, Edinger AL. Nutrient transporters: the Achilles' heel of anabolism. Trends Endocrinol Metab 2013;24:200-8. [PMID: 23402769 DOI: 10.1016/j.tem.2013.01.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
90 Tumova S, Kerimi A, Porter KE, Williamson G. Transendothelial glucose transport is not restricted by extracellular hyperglycaemia. Vascular Pharmacology 2016;87:219-29. [DOI: 10.1016/j.vph.2016.11.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
91 Ząbczyńska M, Kozłowska K, Pocheć E. Glycosylation in the Thyroid Gland: Vital Aspects of Glycoprotein Function in Thyrocyte Physiology and Thyroid Disorders. Int J Mol Sci 2018;19:E2792. [PMID: 30227620 DOI: 10.3390/ijms19092792] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
92 Patra M, Johnstone TC, Suntharalingam K, Lippard SJ. A Potent Glucose-Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells. Angew Chem Int Ed Engl 2016;55:2550-4. [PMID: 26749149 DOI: 10.1002/anie.201510551] [Cited by in Crossref: 96] [Cited by in F6Publishing: 85] [Article Influence: 16.0] [Reference Citation Analysis]
93 Gill KS, Fernandes P, O'Donovan TR, McKenna SL, Doddakula KK, Power DG, Soden DM, Forde PF. Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response. Biochim Biophys Acta 2016;1866:87-105. [PMID: 27373814 DOI: 10.1016/j.bbcan.2016.06.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 49] [Article Influence: 5.0] [Reference Citation Analysis]
94 Shinoda Y, Kujirai K, Aoki K, Morita M, Masuda M, Zhang L, Kaixin Z, Nomoto A, Takahashi T, Tsuneoka Y, Akimoto J, Kataoka H, Rachi R, Narumi A, Yoshimura T, Yano S, Fujiwara Y. Novel Photosensitizer β-Mannose-Conjugated Chlorin e6 as a Potent Anticancer Agent for Human Glioblastoma U251 Cells. Pharmaceuticals (Basel) 2020;13:E316. [PMID: 33081106 DOI: 10.3390/ph13100316] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
95 Sahoo S, Aurich MK, Jonsson JJ, Thiele I. Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease. Front Physiol 2014;5:91. [PMID: 24653705 DOI: 10.3389/fphys.2014.00091] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 6.1] [Reference Citation Analysis]
96 Mumcuoglu D, Sardan Ekiz M, Gunay G, Tekinay T, Tekinay AB, Guler MO. Cellular Internalization of Therapeutic Oligonucleotides by Peptide Amphiphile Nanofibers and Nanospheres. ACS Appl Mater Interfaces 2016;8:11280-7. [PMID: 27097153 DOI: 10.1021/acsami.6b01526] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
97 Carreño D, Corro N, Torres-Estay V, Véliz LP, Jaimovich R, Cisternas P, San Francisco IF, Sotomayor PC, Tanasova M, Inestrosa NC, Godoy AS. Fructose and prostate cancer: toward an integrated view of cancer cell metabolism. Prostate Cancer Prostatic Dis 2019;22:49-58. [PMID: 30104655 DOI: 10.1038/s41391-018-0072-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
98 Hsieh I, Gopula B, Chou C, Wu H, Chang G, Wu W, Chang C, Chu P, Chen CS. Development of Novel Irreversible Pyruvate Kinase M2 Inhibitors. J Med Chem 2019;62:8497-510. [DOI: 10.1021/acs.jmedchem.9b00763] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
99 Poff A, Koutnik AP, Egan KM, Sahebjam S, D'Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Semin Cancer Biol 2019;56:135-48. [PMID: 29294371 DOI: 10.1016/j.semcancer.2017.12.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]